Abstract
Cancer is one of the major causes of death worldwide, and persistent oxidative stress is considered as a proactive contributor to its pathogenesis. Oxidative stress is mainly identified by an increased level of reactive oxygen species (ROS) and reduced antioxidant defense system. Various exogenous and endogenous factors and altered metabolic processes produce different types of ROS that cause DNA damage, mutation, production of pro-carcinogens, and induced programmed cell death. These ROS alter various signaling pathways such as NF-kB, Nrf2, Akt/PI3K/mTOR, MAPK, p53, etc. which further regulate other downstream signaling molecules such as CREB, c-Myc, c-Jun, c-fos, etc., leading to initiation and progression of tumorigenesis. ROS also regulate the mechanism of angiogenesis and ensure the growth, survival, as well as invasion of tumor cells. Apart from cross talk between different signaling molecules, ROS and miRNAs work in close proximity and participate in tumorigenesis. Looking into the pro-carcinogenic role of ROS, many natural and synthetic antioxidants have been explored for their anticancer effect. These antioxidants not only abrogate the progression, proliferation, and invasion of tumors but also protect the healthy cells from the deleterious effect of anticancer drugs. However, another hypothesis justifies the anticancer effect of ROS and its need to increase the sensitivity of tumor cells toward the anticancer drug. Thus, it can be said that ROS act as a double-edged sword, and a fine line or boundary exists between the use of antioxidant drug and the need of ROS for management and treatment of cancer.
Similar content being viewed by others
References
Aggarwal V et al (2019) Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomol Ther 9:735
Ahmad A, Syed FA, Singh S, Hadi S (2005) Prooxidant activity of resveratrol in the presence of copper ions: mutagenicity in plasmid DNA. Toxicol Lett 159:1–12
Bost F, Kaminski L (2019) The metabolic modulator PGC-1α in cancer. Am J Cancer Res 9:198
Boutwell RK, Sivak A (1973) The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol 2:419–444
Braglia L, Zavatti M, Vinceti M, Martelli AM, Marmiroli S (2020) Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: still a potential druggable target? Biochim Biophys Acta (BBA) Mol Cell Res:118731
Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257
Chen J, Wang A, Chen Q (2017) SirT3 and p53 deacetylation in aging and cancer. J Cell Physiol 232:2308–2311
Chierto E, Cristinziano G, Sapone F, Meffre D, Jafarian-Tehrani M (2020) Effect of Etazolate on ROS production after tBHP-induced oxidative stress in oligodendroglial 158 N cell line. React Oxyg Species 9:22-35–22-35
Chiu H-W, Chen Y-A, Ho S-Y, Wang Y-J (2012) Arsenic trioxide enhances the radiation sensitivity of androgen-dependent and-independent human prostate cancer cells. PLoS One:7
Daniel P et al (2017) PI3K activation in neural stem cells drives tumorigenesis which can be suppressed by targeting. CREB bioRxiv:143388
Dolcet X, Llobet D, Pallares J, Matias-Guiu X (2005) NF-kB in development and progression of human cancer. Virchows Arch 446:475–482
Dunn KL, Espino PS, Drobic B, He S, Davie JR (2005) The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol 83:1–14
Fang J, Zhou Q, Liu L-Z, Xia C, Hu X, Shi X, Jiang B-H (2007) Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression. Carcinogenesis 28:858–864
Feitelson MA et al (2015) Sustained proliferation in cancer: mechanisms and novel therapeutic targets. In: Seminars in cancer biology. Elsevier, pp S25–S54
He J et al (2012) Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation. EMBO Rep 13:1116–1122
Hong B, van den Heuvel PJ, Prabhu V, Zhang S, El-Deiry W (2014) Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities. Curr Drug Targets 15:80–89
Hoxhaj G, Manning BD (2019) The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer:1–15
Huang M, Xin W (2018) Matrine inhibiting pancreatic cells epithelial-mesenchymal transition and invasion through ROS/NF-κB/MMPs pathway. Life Sci 192:55–61
Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA (2019) MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Asp Med 70:3–20
Iqubal A et al (2019a) Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision. Life Sci 218:112–131
Iqubal A et al (2019b) Nerolidol attenuates cyclophosphamide-induced cardiac inflammation, apoptosis and fibrosis in Swiss Albino mice. Eur J Pharmacol 863:172666
Iqubal A, Sharma S, Najmi AK, Syed MA, Ali J, Alam MM, Haque SE (2019c) Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: plausible role of Nrf2 and NF-κB. Life Sci 236:116867
Je JH, Lee JY, Jung KJ, Sung B, Go EK, Yu BP, Chung HY (2004) NF-κB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway. FEBS Lett 566:183–189
Kashyap D, Tuli HS, Sak K, Garg VK, Goel N, Punia S, Chaudhary A (2019) Role of reactive oxygen species in cancer progression. Curr Pharmacol Rep 5:79–86
Khan G, Haque SE, Anwer T, Ahsan MN, Safhi MM, Alam M (2014) Cardioprotective effect of green tea extract on doxorubicin-induced cardiotoxicity in rats. Acta Pol Pharm 71:861–868
Khromova N, Kopnin P, Stepanova E, Agapova L, Kopnin B (2009) p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway. Cancer Lett 276:143–151
Li A, Wang J, Wu M, Zhang X, Zhang H (2015) The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27Kip1 induction by interfering with PI3K/Akt/FOXO3a signaling pathway. Eur J Pharmacol 747:71–87
Li R, Quan Y, Xia W (2018) SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway. Exp Cell Res 364:143–151
Li T et al (2019) Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway. Artif Cells Nanomed Biotechnol 47:4001–4011
Liou G-Y, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44:479–496
Liu Y et al (2015) Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells. Oncotarget 6:38983
Luo K-W, Chen W, Lung W-Y, Wei X-Y, Cheng B-H, Cai Z-M, Huang W-R (2017) EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9. J Nutr Biochem 41:56–64
Mori K, Uchida T, Yoshie T, Mizote Y, Ishikawa F, Katsuyama M, Shibanuma M (2019) A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells. FEBS J 286:459–478
Moro L (2019) Mitochondrial dysfunction in aging and cancer. J Clin Med 8:1983
Nguyen TT, Ung TT, Li S, Lian S, Xia Y, Park SY, Do Jung Y (2019) Metformin inhibits lithocholic acid-induced interleukin 8 upregulation in colorectal cancer cells by suppressing ROS production and NF-kB activity. Sci Rep 9:1–13
Paunkov A, Chartoumpekis DV, Ziros PG, Sykiotis GP (2019) A bibliometric review of the Keap1/Nrf2 pathway and its related antioxidant compounds. Antioxidants 8:353
Pei X et al (2019) Oenothein B inhibits human non-small cell lung cancer A549 cell proliferation by ROS-mediated PI3K/Akt/NF-κB signaling pathway. Chem Biol Interact 298:112–120
Prasad S, Srivastava SK (2020) Oxidative stress and cancer: chemopreventive and therapeutic role of Triphala. Antioxidants 9:72
Raj L et al (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475:231–234
Reid MA, Wang W-I, Rosales KR, Welliver MX, Pan M, Kong M (2013) The B55α subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation. Mol Cell 50:200–211
Shaw AT et al (2011) Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proc Natl Acad Sci 108:8773–8778
Storz P (2013) Oxidative stress in cancer. In: Oxidative stress and redox regulation. Springer, pp 427–447
Tang Z et al (2016) CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway. Mol Oncol 10:317–329
Teng J-F et al (2020) Polyphyllin VI induces Caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer. Cancers 12:193
Wang Q et al (2013) Nrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene. Acta Biochim Biophys Sin 45:179–187
Wang C et al (2017) Cholesterol enhances colorectal cancer progression via ROS elevation and MAPK signaling pathway activation. Cell Physiol Biochem 42:729–742
Wang L et al (2018) Calcium and CaSR/IP3R in prostate cancer development. Cell Biosci 8:16
Yang W, Lu Z (2013) Regulation and function of pyruvate kinase M2 in cancer. Cancer Lett 339:153–158
Zhang K et al (2018) miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma. Mol Carcinog 57:1566–1576
Zhang X, Huang J, Yu C, Xiang L, Li L, Shi D, Lin F (2020) Quercetin enhanced paclitaxel therapeutic effects towards PC-3 prostate cancer through ER stress induction and ROS production. Onco Targets Ther 13:513
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Iqubal, A., Haque, S.E. (2022). Molecular Mechanism of Oxidative Stress in Cancer and Its Therapeutics. In: Chakraborti, S. (eds) Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer, Singapore. https://doi.org/10.1007/978-981-16-1247-3_150-1
Download citation
DOI: https://doi.org/10.1007/978-981-16-1247-3_150-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-1247-3
Online ISBN: 978-981-16-1247-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences